The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With Functional Mitral Regurgitation
Cardiac Dimensions, Inc.
300 participants
Jan 1, 2018
INTERVENTIONAL
Conditions
Summary
The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Carillon implant is designed to be deployed, tensioned, and locked in the coronary vein in order to reshape the mitral annulus and thus reduce mitral annular dilation and mitral regurgitation.
Heart failure medication per ACC/AHA guidelines
Locations(92)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03142152